Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

Eugene Shenderov; Karim Boudadi; Wei Fu; Hao Wang; Rana Sullivan; Alice Jordan; Donna Dowling; Rana Harb; Joseph Schonhoft; Adam Jendrisak; Michael A. Carducci; Mario A. Eisenberger; James R. Eshleman; Jun Luo; Charles G. Drake; Drew M. Pardoll; Emmanuel S. Antonarakis

doi:10.1002/pros.24110

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

The Prostate ◽

10.1002/pros.24110 ◽

2021 ◽

Vol 81 (6) ◽

pp. 326-338

Author(s):

Eugene Shenderov ◽

Karim Boudadi ◽

Wei Fu ◽

Hao Wang ◽

Rana Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

BJU International ◽

10.1111/bju.14876 ◽

2019 ◽

Vol 124 ◽

pp. 5-13 ◽

Cited By ~ 20

Author(s):

Michael S. Hofman ◽

Louise Emmett ◽

John Violet ◽

Alison Y. Zhang ◽

Nicola J. Lawrence ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Cancer Clinical Trial ◽

Trial Protocol ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Clinical Trial Protocol ◽

Phase 2 Trial ◽

Castration Resistant ◽

Randomized Phase 2

Download Full-text

A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer

Cancer ◽

10.1002/cncr.29927 ◽

2016 ◽

Vol 122 (12) ◽

pp. 1897-1904 ◽

Cited By ~ 27

Author(s):

Helen Chow ◽

Paramita M. Ghosh ◽

Ralph deVere White ◽

Christopher P. Evans ◽

Marc A. Dall'Era ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Phase 2 Clinical Trial

Download Full-text

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial

European Urology ◽

10.1016/j.eururo.2021.08.011 ◽

2021 ◽

Author(s):

Edmond M. Kwan ◽

Lavinia Spain ◽

Angelyn Anton ◽

Chun L. Gan ◽

Linda Garrett ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Stereotactic Ablative Body Radiotherapy

Download Full-text

Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2019.08.015 ◽

2020 ◽

Vol 38 (3) ◽

pp. 79.e15-79.e22 ◽

Cited By ~ 1

Author(s):

Daniel J. George ◽

Susan Halabi ◽

Patrick Healy ◽

Darius Jonasch ◽

Monika Anand ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Phase 2 Clinical Trial

Download Full-text

Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1118816.793494158 ◽

2014 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase I ◽

Abiraterone Acetate ◽

Selective Inhibitor ◽

Phase I Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

A Phase 2, Randomized, Open-Label, Multi-arm Study of TAS-115 for Castration-Resistant Prostate Cancer Patients With Bone Metastases

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2021.07.013 ◽

2021 ◽

Author(s):

Nobuaki Matsubara ◽

Hirotsugu Uemura ◽

Satoshi Nagamori ◽

Hiroyoshi Suzuki ◽

Hiroji Uemura ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Metastases ◽

Cancer Patients ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Castration Resistant

Download Full-text

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

Investigational New Drugs ◽

10.1007/s10637-012-9869-8 ◽

2012 ◽

Vol 31 (3) ◽

pp. 760-768 ◽

Cited By ~ 143

Author(s):

Kenneth J. Pienta ◽

Jean-Pascal Machiels ◽

Dirk Schrijvers ◽

Boris Alekseev ◽

Mikhail Shkolnik ◽

...

Keyword(s):

Prostate Cancer ◽

Monoclonal Antibody ◽

Human Monoclonal Antibody ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Phase 2 Study ◽

Chemokine Ligand ◽

Cc Chemokine Ligand 2 ◽

Chemokine Ligand 2

Download Full-text

Faculty Opinions recommendation of [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739562946.793583755 ◽

2021 ◽

Author(s):

Patrick Richard

Keyword(s):

Prostate Cancer ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Phase 2 Trial ◽

Castration Resistant ◽

Open Label Phase

Download Full-text

A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer

Cancer Immunology Immunotherapy ◽

10.1007/s00262-015-1781-6 ◽

2016 ◽

Vol 65 (2) ◽

pp. 151-160 ◽

Cited By ~ 38

Author(s):

Masanori Noguchi ◽

Fukuko Moriya ◽

Noriko Koga ◽

Satoko Matsueda ◽

Tetsuro Sasada ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Peptide Vaccination ◽

Castration Resistant ◽

Randomized Phase Ii

Download Full-text

Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial

Annals of Oncology ◽

10.1093/annonc/mdu510 ◽

2015 ◽

Vol 26 (1) ◽

pp. 179-185 ◽

Cited By ~ 42

Author(s):

D. Cella ◽

C. Ivanescu ◽

S. Holmstrom ◽

C.N. Bui ◽

J. Spalding ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text